Molecules/ISATUXIMAB

ISATUXIMAB

Molecular Identity

AntibodyApprovedFirst approved 2020

Mechanism of action: Lymphocyte differentiation antigen CD38 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ISATUXIMABISATUXIMAB IRFCISATUXIMAB-IRFCSAR-650984SAR650984Sarclisa

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to ISATUXIMAB

Loading drug network...